SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of…

Overview of attention for article published in Frontiers in oncology, May 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 10,456 followers.

https://t.co/sHPzInKrvp SOCS3の発現が多いのはあまりよくなさそう。だとすれば、Prdm14の抑制はあまり良くない結果になるのでは？

13 Oct 2022

Reply Repost Favourite

SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer #lymphoma #lymsm https://t.co/xSR3VaKmlZ

23 May 2022

Reply Repost Favourite

New in Pubmed: "SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer" https://t.co/Tb9DFo35zC

23 May 2022

Reply Repost Favourite

23 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.